Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

10069	Companies
205865	Keywords
136128	Articles
109157	Press releases

Home
Companies
Biophytis

PRESS RELEASE

published on 03/22/2024 at 07:01, 2 years ago

Biophytis a présenté son protocole de phase 3 dans le traitement de la sarcopénie
Biophytis a présenté son protocole de phase 3 dans le traitement de la sarcopénie lors de l’ICFSR. L'étude SARA-31 vise à évaluer l'efficacité de RuvembriTM. La société recherche des partenaires pharmaceutiques pour le développer

Biophytis RuvembriTM Sarcopénie ICFSR Protocole De Phase 3
PRESS RELEASE

published on 03/22/2024 at 07:01, 2 years ago

Biophytis presented its phase 3 protocol in the treatment of sarcopenia
Biophytis presented its phase 3 protocol for treating sarcopenia with Ruvembri at ICFSR conference, showing promising results in phase 2 study

Biophytis Ruvembri Phase 3 Protocol Sarcopenia Treatment ICFSR Conference
REGULATED PRESS RELEASE

published on 03/22/2024 at 07:00, 2 years ago

Biophytis a présenté son protocole de phase 3 dans le traitement de la sarcopénie
Biophy's présente son protocole de phase 3 pour traiter la sarcopénie lors de l'ICFSR. L'étude SARA-31 évaluera l'efficacité de RuvembriTM. Biophytis recherche des partenaires pour le développement

Biophytis RuvembriTM Sarcopénie Biophy's Protocole De Phase 3
REGULATED PRESS RELEASE

published on 03/22/2024 at 07:00, 2 years ago

Biophytis presented its phase 3 protocol in the treatment of sarcopenia
Biophytis presents phase 3 protocol for sarcopenia treatment at ICFSR conference, showcasing the potential of RuvembriTM. CEO Stanislas Veillet seeks partners for drug development and financing

Biophytis RuvembriTM Clinical-stage Biotechnology Phase 3 Protocol Sarcopenia Treatment
BRIEF

published on 03/18/2024 at 07:05, 2 years ago

Biophytis annonce sa prochaine Assemblée Générale Mixte pour le 02 avril 2024

Biophytis Assemblée Générale Mixte Société Biotechnologique Vote Des Actionnaires Médicaments Vieillissement
BRIEF

published on 03/18/2024 at 07:05, 2 years ago

Biophytis Announces Combined General Meeting for April 2024

Biophytis RuvembriTM Clinical-stage Biotechnology Combined General Meeting Age-related Diseases
REGULATED PRESS RELEASE

published on 03/18/2024 at 07:00, 2 years ago

Assemblée générale mixte du 02 avril 2024
Assemblée générale mixte de Biophytis SA prévue le 02 avril 2024 à Paris. Actionnaires invités à voter en amont. Informations sur le site internet de la Société

Assemblée Générale Mixte Biophytis SA Vote Actionnaires Développement Médicaments Maladies Liées Au Vieillissement
REGULATED PRESS RELEASE

published on 03/18/2024 at 07:00, 2 years ago

Combined General Meeting of April 2, 2024
Biophytis SA will hold its Combined General Meeting (CGM) on April 2, 2024 at Sorbonne Université, Paris. Shareholders can vote in advance. The company specializes in developing therapies for age-related diseases

Therapeutics Combined General Meeting Biophytis SA Age-related Diseases CGM
BRIEF

published on 03/15/2024 at 23:05, 2 years ago

Biophytis met en œuvre le regroupement de ses actions pour réduire la volatilité

Marché Financier Biophytis Biotechnologie Regroupement D'actions Volatilité Du Titre
BRIEF

published on 03/15/2024 at 23:05, 2 years ago

Biophytis Announces Reverse Stock Split on Euronext Growth

Biophytis Biotechnology Shareholder Value Reverse Stock Split Euronext Growth

Accesswire

Published on 03/24/2026 at 00:55, 5 hours 22 minutes ago

BTU Closes Oversubscribed Financing
Published on 03/23/2026 at 22:40, 7 hours 37 minutes ago

Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/23/2026 at 22:30, 7 hours 47 minutes ago

Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp
Published on 03/23/2026 at 22:00, 8 hours 17 minutes ago

Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 8 hours 59 minutes ago

Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer

View all ACCESSWIRE

EQS Group

Published on 03/24/2026 at 06:00, 17 minutes ago

51st Annual General Meeting of BELIMO Holding AG Approves All Motions
Published on 03/24/2026 at 06:00, 17 minutes ago

SKAN with good order intake in the 2025 financial year
Published on 03/24/2026 at 05:10, 1 hour 7 minutes ago

Huawei Releases the NG WAN White Paper to Fully Upgrade IP Bearer Networks and Drive New Growth for Carriers
Published on 03/24/2026 at 02:00, 4 hours 17 minutes ago

Discover a season of arts and sports mega events in Hong Kong
Published on 03/24/2026 at 00:55, 5 hours 22 minutes ago

mymediset Introduces Agentic AI for MedTech Supply Chains at LogiMed 2026

Les Echos

Published on 03/23/2026 at 19:08, 11 hours 9 minutes ago

Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 11 hours 9 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 11 hours 40 minutes ago

ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 12 hours 32 minutes ago

ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 12 hours 32 minutes ago

En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde

View all LES ECHOS COMFI WIRE